Reported Consolidated quarterly numbers for Astec Lifesciences are:
Net Sales at Rs 142.85 crore in June 2023 down 22.48% from Rs. 184.27 crore in June 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 8.19 crore in June 2023 down 171.88% from Rs. 11.40 crore in June 2022.
EBITDA stands at Rs. 4.85 crore in June 2023 down 82.78% from Rs. 28.16 crore in June 2022.
Astec Life shares closed at 1,234.10 on July 27, 2023 (NSE) and has given -18.95% returns over the last 6 months and -33.71% over the last 12 months.
Story continues below Advertisement
| Astec Lifesciences | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Jun'23 | Mar'23 | Jun'22 | | Net Sales/Income from operations | 142.85 | 126.97 | 184.27 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 142.85 | 126.97 | 184.27 | | EXPENDITURE | | Consumption of Raw Materials | 120.77 | 76.49 | 138.64 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | -18.16 | 9.76 | -16.16 | | Power & Fuel | -- | -- | -- | | Employees Cost | 15.38 | 12.86 | 12.98 | | Depreciation | 9.39 | 7.76 | 8.93 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 21.73 | 22.47 | 23.36 | | P/L Before Other Inc., Int., Excpt. Items & Tax | -6.25 | -2.36 | 16.52 | | Other Income | 1.71 | 2.57 | 2.71 | | P/L Before Int., Excpt. Items & Tax | -4.54 | 0.22 | 19.23 | | Interest | 6.46 | 6.40 | 3.92 | | P/L Before Exceptional Items & Tax | -11.01 | -6.18 | 15.31 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -11.01 | -6.18 | 15.31 | | Tax | -2.82 | -1.21 | 3.90 | | P/L After Tax from Ordinary Activities | -8.19 | -4.98 | 11.41 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -8.19 | -4.98 | 11.41 | | Minority Interest | -0.01 | -0.01 | -0.01 | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | -8.19 | -4.98 | 11.40 | | Equity Share Capital | 19.61 | 19.61 | 19.60 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -4.18 | -2.54 | 5.82 | | Diluted EPS | -4.18 | -2.54 | 5.81 | | EPS After Extra Ordinary | | Basic EPS | -4.18 | -2.54 | 5.82 | | Diluted EPS | -4.18 | -2.54 | 5.81 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
